Civic Intelligence

Cohen Veterans Bioscience Inc.

990 • Fiscal year 2020 • EIN 47-1981973

Jul 01, 2019 to Jun 30, 2020 • Filed on Oct 26, 2020

Organization ProfileWWW.COHENVETERANSBIOSCIENCE.ORG

View Organization Page

1 Broadway 14th FloorCambridge, MA 02142

(646) 970-4325

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

68th percentile

0.45x

Higher debt load relative to assets than 68% of similar nonprofits.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2020

Liabilities / Revenue

66th percentile

0.51x

Higher debt load relative to revenue than 66% of similar nonprofits.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2020

Net Margin

18th percentile

-10%

Higher net margin than 18% of similar nonprofits.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2020

Top Officer Pay

93rd percentile

$654,191

Higher top officer pay than 93% of similar nonprofits.

Top officer pay equals 4.0% of source-year revenue.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2020

Asset Growth

3rd percentile

-22%

Faster asset growth than 3% of similar nonprofits.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2019 to 2020

Revenue Growth

18th percentile

-22%

Faster revenue growth than 18% of similar nonprofits.

2020 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets68th percentile

Assets

Down

$18,865,456

Down $5,324,813 (-22%) from 2019

Net Assets

Down

$10,433,696

Down $767,652 (-6.9%) from 2019

Liabilities

Down

$8,431,760

Down $4,557,161 (-35%) from 2019

Revenue And Expenses
Liabilities / Revenue66th percentileNet Margin18th percentile

Revenue

Down

$16,470,665

Down $4,568,783 (-22%) from 2019

Expenses

Down

$18,162,920

Down $2,008,017 (-10.0%) from 2019

Net Income

Down

-$1,692,255

Down $2,560,766 (-295%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth3rd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0-$10MAssets 2015: $450,595Liabilities 2015: $326,443Net Assets 2015: $124,1522015Assets 2016: $25,419,016Liabilities 2016: $10,161,873Net Assets 2016: $15,257,1432016Assets 2017: $14,863,415Liabilities 2017: $6,579,459Net Assets 2017: $8,283,9562017Assets 2018: $16,353,364Liabilities 2018: $6,020,527Net Assets 2018: $10,332,8372018Assets 2019: $24,190,269Liabilities 2019: $12,988,921Net Assets 2019: $11,201,3482019Assets 2020: $18,865,456Liabilities 2020: $8,431,760Net Assets 2020: $10,433,6962020Assets 2021: $17,952,584Liabilities 2021: $6,826,523Net Assets 2021: $11,126,0612021Assets 2022: $15,587,351Liabilities 2022: $3,699,826Net Assets 2022: $11,887,5252022Assets 2023: $11,743,398Liabilities 2023: $3,853,705Net Assets 2023: $7,889,6932023Assets 2024: $3,075,275Liabilities 2024: $3,105,844Net Assets 2024: -$30,5692024Assets 2025: $1,835,419Liabilities 2025: $98,368Net Assets 2025: $1,737,0512025

Highlighted filing

2020

Assets$18,865,456
Liabilities$8,431,760
Net Assets$10,433,696
Open 2020 Filing

Operations Trend

Revenue Growth18th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MRevenue 2015: $70,035Expenses 2015: $651,553Net Income 2015: -$581,5182015Revenue 2016: $31,399,759Expenses 2016: $16,266,768Net Income 2016: $15,132,9912016Revenue 2017: $4,366,629Expenses 2017: $11,339,816Net Income 2017: -$6,973,1872017Revenue 2018: $16,845,541Expenses 2018: $14,796,660Net Income 2018: $2,048,8812018Revenue 2019: $21,039,448Expenses 2019: $20,170,937Net Income 2019: $868,5112019Revenue 2020: $16,470,665Expenses 2020: $18,162,920Net Income 2020: -$1,692,2552020Revenue 2021: $16,252,270Expenses 2021: $18,110,420Net Income 2021: -$1,858,1502021Revenue 2022: $18,082,398Expenses 2022: $17,523,784Net Income 2022: $558,6142022Revenue 2023: $11,343,534Expenses 2023: $15,341,366Net Income 2023: -$3,997,8322023Revenue 2024: $8,377,751Expenses 2024: $14,079,910Net Income 2024: -$5,702,1592024Revenue 2025: $3,369,809Expenses 2025: $1,377,761Net Income 2025: $1,992,0482025

Highlighted filing

2020

Revenue$16,470,665
Expenses$18,162,920
Net Income-$1,692,255
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2019 to Jun 30, 2020
Signed
Oct 26, 2020
Return Version
2019v5.1
Gross Receipts
$16,470,665
Mission and Program Overview

Mission

Cohen veterans bioscience is the only 501(c)3 non-profit research organization with a singular focus on ptsd and tbi research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.

Fast-tracking precision diagnostics and personalized therapeutics for advancing brain health

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$16,036,550$15,130,098▼ $906,452
Pledges and Grants Receivable$7,527,477$2,302,389▼ $5,225,088
Cash and Non-Interest-Bearing Accounts$465,961$690,470▲ $224,509
Land, Buildings, and Equipment, Net$50,226$284,318▲ $234,092
Prepaid Expenses and Deferred Charges$61,526$88,022▲ $26,496
Total Assets$24,190,269$18,865,456▼ $5,324,813
Other Assets Total$48,529$370,159▲ $321,630
Liabilities
Grants Payable$10,118,262$5,348,290▼ $4,769,972
Accounts Payable and Accrued Expenses$2,672,945$2,942,644▲ $269,699
Other Liabilities$0$131,804▲ $131,804
Deferred Revenue$197,714$9,022▼ $188,692
Total Liabilities$12,988,921$8,431,760▼ $4,557,161
Net Assets / Fund Balance
Net Assets With Donor Restrictions$10,360,356$7,387,725▼ $2,972,631
Net Assets Without Donor Restrictions$840,992$3,045,971▲ $2,204,979
Total Net Assets Fund Balance$11,201,348$10,433,696▼ $767,652
Total Liabilities and Net Assets / Fund Balance$24,190,269$18,865,456▼ $5,324,813

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$154,671$19,405$174,076
Leasehold Improvements$124,528$9,834$134,362
Other Land Buildings$5,119$6,398$11,517
Compensation and Service Providers
Top Officer Pay93rd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Magali Haas Md PhdCEO & PresidentFT$454,184$200,007$654,191
Allyson Gage PhdChief Medical OfficerFT$358,257$168,100$526,357
Andreas Jeromin PhdChief Scientific OfficerFT$325,470$157,494$482,964
David BiondiBoard Mbr/former Executive Dir.,clinical ProgramsFT$310,381$28,337$338,718
David BiondiBoard Mbr/former Executive Dir.,clin-$260,031$78,687$338,718
Daniela Brunner PhdFormer Exec. Director of Digital HealthFT$268,264$59,211$327,475
Amanda Nicole HarmonExecutive Director, External AffairsFT$189,253$75,074$264,327
Friso PostmaFormer Senior Director, Early SignalFT$201,304$13,747$215,051
Linda DysonFormer Executive Director, Public AffairsFT$191,178$4,977$196,155
Linda DysonFormer Executive Director, Public Af-$191,178$4,977$196,155
Deepti ColeAssociate Director, Data ScienceFT$140,990$8,583$149,573
Daniel PlowdenChief Financial OfficerFT$49,221$5,568$54,789

Board Members and Trustees

NameTitle
Douglas HaynesBoard Member
Theresa FrangiosaSecretary
Michael SullivanTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Morgan Lewis And Bockius LLPLegal Services1701 MARKET STREET, Philadelphia, PA 19103, Uk$654,428
Grf Cpa's & AdvisorsAccounting And Bookkeeping4550 MONTGOMERY AVENUE SUITE 800, North Bethesda, MD 20814$367,411
Deep Net Ai LtdChief Information Officer6 DIGITAL DRIVE UNIT 302, Nashua, NH 03062$314,557
Advanced Strategic Technology LLCStrategic It Advisor63 PUTNUM STREET SUITE 2020, Saratoga Springs, NY 12866$190,108
Tone Creative LLCMarketing And Design Services-$179,815
Revenue and Support

Revenue Composition

Contributions and Grants
$16,316,026
Program Service Revenue
$0
Investment Income
$154,639
Other Revenue
$0
All Other Contributions
$14,321,582
Change in Net Assets
$-1,692,255

Audited Revenue Reconciliation

Revenue per Audited Statements
$16,470,665
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$16,470,665
Total Revenue per Form 990
$16,470,665
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$9,950,539
Salaries, Compensation, and Employee Benefits$7,099,520
Grants and Similar Amounts Paid$1,112,861
Total Fundraising Expense$27,526
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$6,514,137$132,754$18,014$6,664,905
Other Salaries and Wages$3,586,290$403,318$1,052$3,990,660
Current Officers, Directors, Trustees, and Key Employees$1,791,228$432,175$6,827$2,230,230
Grants to Domestic Orgs$1,043,394--$1,043,394
Fees for Services Legal$254,639$419,057-$673,696
Occupancy$470,196$110,243-$580,439
Fees for Services Accounting-$515,166-$515,166
Travel$296,367$107,338$340$404,045
Payroll Taxes$320,048$50,011$468$370,527
Office Expenses$198,468$128,289$92$326,849
Fees for Services Management-$289,832-$289,832
Other Employee Benefits$238,418$40,021$396$278,835
Pension Plan Contributions$200,336$28,764$168$229,268
Information Technology$139,845$61,006$55$200,906
Conferences and Meetings$95,784$8,268-$104,052
Fees for Services Lobbying$90,000--$90,000
Foreign Grants$69,467--$69,467
Insurance$40,851$14,888$59$55,798
Depreciation Depletion$37,943$6,778$55$44,776
Other Expenses-$75-$75
Total Functional Expenses$15,387,411$2,747,983$27,526$18,162,920

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$18,162,920
Total Expenses per Audited Statements$18,162,920
Total Expenses per Form 990$18,162,920
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of ChicagoChicago, IL501(c)3Provide Services and Support for Brain Commons (data-repository)$635,748
The Broad Institute of Mit and HarvardCambridge, MA501(c)3Ptsd Research Programs$220,784
Open Commons ConsortiumRiver Forest, IL501(c)3Brain Commons Development and Maintenance$143,811
American College of Radiology (acr)Philadelphia, PA501(c)3Conduct Study to Establish a National Normative Neuroimaging Library$78,055
CHILDREN'S HOSPITAL OF PHILADELPHIAPhiladephia, PA501(c)3Validating Constructs Relevant to Ptsd in a Model of Individual Differences in Response to Social Defeat in Rats$60,000
Mhealthforward IncNew York, NY501(c)3Biosensors and Mobile Health Platform for Brain Diseases$60,000
University of California San DiegoLa Jolla, CA501(c)3Analysis of Genetic Data (gwas) in Ptsd Patients$40,090
Mclean HospitalBelmont, MA501(c)3Repurposed Grant Funds-

International Summary

Offices
0
Employees
1
Spending
$392,238

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland)Chief Information OfficerN/a01$322,771
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumGrants to Recipients Located in RegionN/a00$69,467
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
-Owner Is an Officer of the OrganizationProvided Discounted Pharmaceutical Market, Commercialization Landscaping and Strategic Consulting Services to Organization.No$46,350
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent$131,804
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“The board of directors reviewed and approved the form 990 prior to its filing. The form 990 was then authorized and signed by the organization's ceo & president.”

Form 990, Part VI, Section B, Line 12C

“The board of directors requires an annual declaration from all board members and senior management as to the existence and disclosure of any potential conflicts of interest. The board members sign a disclosure statement. Any potential conflicts are discussed by the dis-interested board members, while the party in potential conflict is required to leave the room. Board meeting minutes will document the discussion and decision making process. In the event of a potential conflict, procedures to obtain competitive bids and diligence on fair market value will be established.”

Form 990, Part VI, Section B, Line 15

“Cvb's executive compensation program is administered by the board of directors. The board is responsible for establishing and maintaining a competitive compensation program for the key executives of the organization. The board meets as needed to review the compensation program and make recommendations for any changes, as appropriate. A performance evaluation is conducted and reviewed each year and is intended to ensure that the compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. Following this review, the board reviews and approves, for selected key executives, base salaries and annual incentive opportunity adjustments, and objectives and goals upcoming year's annual incentive plan. The board reviews and recommends to the board salary approval and incentive awards for the ceo/president and selected key senior staff.”

Form 990, Part VI, Section C, Line 19

“Upon request and forms available through charity navigator website as well.”

Filing and Contact Details

Filer

Filer Name
Cohen Veterans Bioscience Inc
EIN
47-1981973
Phone
6469704325
Address
1 BROADWAY 14TH FLOOR, CAMBRIDGE, MA 02142

Signing Officer

Name
Magali Haas Md Phd
Title
CEO & President
Phone
6469704325
Signed
2020-10-26
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Magali Haas Md Phd
Formed
2014
Legal Domicile
Ma
Voting Board Members
5
Independent Board Members
2
Employees
35
Volunteers
0

Preparer

Firm
Smith Sullivan & Brown Pc
Address
80 FLANDERS ROAD - SUITE 200, WESTBOROUGH, MA 01581
Preparer
Sandra M Brown CPA
Phone
5088717178
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Research collaboration expenses: program service expenses 2,783,143. Management and general expenses 0. Fundraising expenses 0. Total expenses 2,783,143. Contracted services: program service expenses 3,730,994. Management and general expenses 132,754. Fundraising expenses 18,014. Total expenses 3,881,762.”

FORM 990, PART XI, LINE 9:

“Cancellation of grant obligation 924,603.”

Financial Statement Notes

PART X, LINE 2:

“Tax position: the organization currently evaluates all tax positions, and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax position made by the organization is the existence of unrelated business income tax and the organization's status as a tax-exempt organization under section 501(c)(3) of the internal revenue code. For the year presented, the organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation.”

Raw XML AppendixShowing 400 of 840 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02672945
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02942644
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0FAST-TRACKING PRECISION DIAGNOSTICS AND PERSONALIZED THERAPEUTICS FOR ADVANCING BRAIN HEALTH
IRS990/AllOtherContributionsAmt014321582
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GELMAN ROSENBERG AND FREEDMAN CPA
IRS990/BooksInCareOfDetail/PhoneNum03019519090
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt04550 MONTGOMERY AVENUE SUITE 650N
IRS990/BooksInCareOfDetail/USAddress/CityNm0BETHESDA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020814
IRS990/BusinessRlnWith35CtrlEntInd01
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0465961
IRS990/CashNonInterestBearingGrp/EOYAmt0690470
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt016
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt06827
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0432175
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01791228
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02230230
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt08268
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt095784
IRS990/ConferencesMeetingsGrp/TotalAmt0104052
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0654428
IRS990/ContractorCompensationGrp/CompensationAmt1367411
IRS990/ContractorCompensationGrp/CompensationAmt2314557
IRS990/ContractorCompensationGrp/CompensationAmt3190108
IRS990/ContractorCompensationGrp/CompensationAmt4179815
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt012 MANOR FIELDS ALREWAS BURTON ON
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0STRAFFORD DEDA
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0UK
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01701 MARKET STREET
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt14550 MONTGOMERY AVENUE SUITE 800
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt26 DIGITAL DRIVE UNIT 302
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt363 PUTNUM STREET SUITE 2020
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0PHILADELPHIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1NORTH BETHESDA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2NASHUA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm3SARATOGA SPRINGS
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0PA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2NH
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd3NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd019103
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd120814
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd203062
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd312866
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0MORGAN LEWIS AND BOCKIUS LLP
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1GRF CPA'S & ADVISORS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2DEEP NET AI LTD
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3ADVANCED STRATEGIC TECHNOLOGY LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4TONE CREATIVE LLC
IRS990/ContractorCompensationGrp/ServicesDesc0LEGAL SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc1ACCOUNTING AND BOOKKEEPING
IRS990/ContractorCompensationGrp/ServicesDesc2CHIEF INFORMATION OFFICER
IRS990/ContractorCompensationGrp/ServicesDesc3STRATEGIC IT ADVISOR
IRS990/ContractorCompensationGrp/ServicesDesc4MARKETING AND DESIGN SERVICES
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt016316026
IRS990/CYGrantsAndSimilarPaidAmt01112861
IRS990/CYInvestmentIncomeAmt0154639
IRS990/CYOtherExpensesAmt09950539
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-1692255
IRS990/CYSalariesCompEmpBnftPaidAmt07099520
IRS990/CYTotalExpensesAmt018162920
IRS990/CYTotalFundraisingExpenseAmt027526
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt016470665
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0197714
IRS990/DeferredRevenueGrp/EOYAmt09022
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt055
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt06778
IRS990/DepreciationDepletionGrp/ProgramServicesAmt037943
IRS990/DepreciationDepletionGrp/TotalAmt044776
IRS990/Desc0BRAIN HEALTH PLATFORMSIN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND PERSONALIZED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS TOOLS AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES. WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAIN COMMONS (CLOUD-BASED DATA SHARING), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS) AND BRAIN-NET (A CLINICAL TRIAL INFRASTRUCTURE TO EXECUTE TURN-KEY EARLY PHASE CLINICAL STUDIES).BRAIN COMMONS (TRADEMARKED):BUILDING ON PREVIOUS WORK WITH THE OPEN COMMONS CONSORTIUM AND UNIVERSITY OF CHICAGO, CVB HAS CREATED A CLOUD-ACCESSIBLE AND SECURE DIGITAL ECOSYSTEM TO ENABLE AND STIMULATE DATA SHARING AND ANALYSIS IN BOTH PUBLIC AND PRIVATE DOMAINS, FUELING DISCOVERY AND COLLABORATION ACROSS THE MULTIDISCIPLINARY RESEARCH COMMUNITY, AND DRIVING DIAGNOSTIC AND THERAPEUTIC INNOVATION TO REDUCE THE BURDEN OF BRAIN-BASED DISORDERS. LEADING BRAIN-RELATED DISEASE FOUNDATIONS HAVE ACCESS TO THE PLATFORM TO HOUSE THEIR OWN DATA WITHIN THE COMMONS. EARLYSIGNAL (TRADEMARKED): WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIME - AND TO DEVELOP EARLIER AND PREVENTIVE DIAGNOSTICS AND TREATMENTS TO MAKE A DIFFERENCE IN PATIENTS' LIVES. MEDICAL-GRADE DATA IS NEEDED FOR FDA APPROVAL OF SUCH PLATFORMS FOR USE IN MEDICAL DECISION MAKING AND DATA INTEGRATION IS NECESSARY FOR CLINICIANS' WORKFLOW. THIS PROGRAM SUPPORTS MULTIPLE PARTNERS TO TEST AND VALIDATE WEARABLES, SENSORS, APPS AND OTHER DIGITAL HEALTH TECHNOLOGIES FOR USE IN MONITORING BRAIN HEALTH. A CURRENT EXAMPLE OF SUCH WORK IS CVB'S PARTNERSHIP WITH UNIVERSITY OF PENNSYLVANIA, CONDUCTING A STUDY TO TEST AND VALIDATE THE PERFORMANCE OF WEARABLE AND SENSOR DEVICES, USING CVB DESIGNED SECURE AUTOMATED DEIDENTIFIED DATA COLLECTION AND CVB'S STUDY MANAGER TOOL TO SUPPORT CONDUCT OF THE TRIAL.RAPID-DIAGNOSTICS (RAPID-DX (TRADEMARKED)):A BIOMARKER IS A CHARACTERISTIC THAT IS OBJECTIVELY MEASURED AND EVALUATED AS AN INDICATOR OF A NORMAL OR PATHOLOGIC BIOLOGICAL PROCESS OR A RESPONSE TO A TH
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd01
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt010360356
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt07387725
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt035
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt015387411
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0515166
IRS990/FeesForServicesAccountingGrp/TotalAmt0515166
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0419057
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0254639
IRS990/FeesForServicesLegalGrp/TotalAmt0673696
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt090000
IRS990/FeesForServicesLobbyingGrp/TotalAmt090000
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt0289832
IRS990/FeesForServicesManagementGrp/TotalAmt0289832
IRS990/FeesForServicesOtherGrp/FundraisingAmt018014
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0132754
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt06514137
IRS990/FeesForServicesOtherGrp/TotalAmt06664905
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt069467
IRS990/ForeignGrantsGrp/TotalAmt069467
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt060.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt19.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt018315
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt328337
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt55568
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt615766
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt723900
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt810182
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt98583
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt104977
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1132407
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1212747
IRS990/Form990PartVIISectionAGrp/PersonNm0MAGALI HAAS MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm1THERESA FRANGIOSA
IRS990/Form990PartVIISectionAGrp/PersonNm2MICHAEL SULLIVAN
IRS990/Form990PartVIISectionAGrp/PersonNm3DAVID BIONDI
IRS990/Form990PartVIISectionAGrp/PersonNm4DOUGLAS HAYNES
IRS990/Form990PartVIISectionAGrp/PersonNm5DANIEL PLOWDEN
IRS990/Form990PartVIISectionAGrp/PersonNm6ANDREAS JEROMIN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm7ALLYSON GAGE PHD
IRS990/Form990PartVIISectionAGrp/PersonNm8DANIELA BRUNNER PHD
IRS990/Form990PartVIISectionAGrp/PersonNm9DEEPTI COLE
IRS990/Form990PartVIISectionAGrp/PersonNm10LINDA DYSON
IRS990/Form990PartVIISectionAGrp/PersonNm11AMANDA NICOLE HARMON
IRS990/Form990PartVIISectionAGrp/PersonNm12FRISO POSTMA
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0635876
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3310381
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt549221
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6467198
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7502457
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8317293
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9140990
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10191178
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11231920
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12202304
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MBR/FORMER EXECUTIVE DIR.,CLINICAL PROGRAMS
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5CHIEF FINANCIAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt6CHIEF SCIENTIFIC OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt7CHIEF MEDICAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt8FORMER EXEC. DIR. OF DIGITAL HEALTH
IRS990/Form990PartVIISectionAGrp/TitleTxt9ASSOCIATE DIRECTOR, DATA SCIENCE
IRS990/Form990PartVIISectionAGrp/TitleTxt10FORMER EXECUTIVE DIRECTOR, PUBLIC AFFAIRS
IRS990/Form990PartVIISectionAGrp/TitleTxt11EXECUTIVE DIRECTOR, EXTERNAL AFFAIRS
IRS990/Form990PartVIISectionAGrp/TitleTxt12FORMER SENIOR DIRECTOR, EARLY SIGNAL
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GovernmentGrantsAmt01994444
IRS990/GrantAmt01112861
IRS990/GrantsPayableGrp/BOYAmt010118262
IRS990/GrantsPayableGrp/EOYAmt05348290
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt01043394
IRS990/GrantsToDomesticOrgsGrp/TotalAmt01043394
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt016470665
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt022
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt055
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt061006
IRS990/InformationTechnologyGrp/ProgramServicesAmt0139845
IRS990/InformationTechnologyGrp/TotalAmt0200906
IRS990/InsuranceGrp/FundraisingAmt059
IRS990/InsuranceGrp/ManagementAndGeneralAmt014888
IRS990/InsuranceGrp/ProgramServicesAmt040851
IRS990/InsuranceGrp/TotalAmt055798
IRS990/InvestmentIncomeGrp/ExclusionAmt0154639
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0154639
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt034
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt035637
IRS990/LandBldgEquipBasisNetGrp/BOYAmt050226
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0284318
IRS990/LandBldgEquipCostOrOtherBssAmt0319955
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0COHEN VETERANS BIOSCIENCE IS DEDICATED TO FAST-TRACKING THE DEVELOPMENT OF DIAGNOSTIC TESTS AND PERSONALIZED THERAPEUTICS FOR THE MILLIONS OF VETERANS AND CIVILIANS WHO SUFFER THE DEVASTATING EFFECTS OF TRAUMA-RELATED AND OTHER BRAIN DISORDERS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt011201348
IRS990/NetAssetsOrFundBalancesEOYAmt010433696
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0840992
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt03045971
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0110243
IRS990/OccupancyGrp/ProgramServicesAmt0470196
IRS990/OccupancyGrp/TotalAmt0580439
IRS990/OfficeExpensesGrp/FundraisingAmt092
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0128289
IRS990/OfficeExpensesGrp/ProgramServicesAmt0198468
IRS990/OfficeExpensesGrp/TotalAmt0326849
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt048529
IRS990/OtherAssetsTotalGrp/EOYAmt0370159
IRS990/OtherChangesInNetAssetsAmt0924603
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt0396
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt040021
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0238418
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0278835
IRS990/OtherExpensesGrp/Desc0BAD DEBT EXPENSE
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt075
IRS990/OtherExpensesGrp/TotalAmt075
IRS990/OtherLiabilitiesGrp/BOYAmt00
IRS990/OtherLiabilitiesGrp/EOYAmt0131804
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt01052
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0403318
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt03586290
IRS990/OtherSalariesAndWagesGrp/TotalAmt03990660
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt0468
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt050011
IRS990/PayrollTaxesGrp/ProgramServicesAmt0320048
IRS990/PayrollTaxesGrp/TotalAmt0370527
IRS990/PensionPlanContributionsGrp/FundraisingAmt0168
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt028764
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0200336
IRS990/PensionPlanContributionsGrp/TotalAmt0229268
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt07527477
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt02302389
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt061526
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt088022
IRS990/PrincipalOfficerNm0MAGALI HAAS MD PHD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI, WHICH WE EXPECT TO PUBLISH IN EARLY 2021.CVB CONTINUES TO DEVELOP INNOVATIVE WAYS TO CONVENE AND ENGAGE THOUGHT LEADERS DESPITE THE LIMITATIONS ON LARGE IN-PERSON EVENTS DUE TO COVID-19. OUR EDUCATION AND ADVOCACY WORK HAS CONTINUED ON A FULLY REMOTE BASIS RESULTING IN THE ADVANCEMENT OF IMPORTANT RESEARCH AREAS, AND PLANS ARE BEING MADE FOR AN EVENT IN SUMMER 2021. ADAPTIVE PLATFORM TRIALS:CVB IS SPEARHEADING THE DESIGN AND APPLICATION OF "SMART- OR "ADAPTIVE-" CLINICAL TRIALS FOR NEUROPSYCHIATRIC AND NEURODEGENERATIVE CONDITIONS. THESE STUDIES INCLUDE A PROSPECTIVELY PLANNED OPPORTUNITY FOR MODIFICATION OF ONE OR MORE SPECIFIED ASPECTS OF THE STUDY DESIGN BASED ON DATA (USUALLY INTERIM DATA) COLLECTED FROM SUBJECTS IN THE STUDY. TO EXECUTE SUCH PROGRAMS, OUR CENTRALLY-MANAGED PLATFORM CLINICAL TRIAL INFRASTRUCTURE (BRAIN-NET) WILL BE LEVERAGED TO CONDUCT STUDIES ACROSS BRAIN CONDITIONS AND POPULATIONS INCLUDING ACADEMIC, PRIVATE, VA, AND POTENTIALLY MILITARY RESEARCH CENTERS.CURRENTLY, ONLY TWO DRUGS ARE APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF PTSD, ALTHOUGH BOTH ARE ONLY MODESTLY EFFECTIVE IN TREATING MILITARY-RELATED PTSD. OVER THE PAST 18 YEARS, INDIVIDUAL ACADEMIC INVESTIGATORS AND COMPANIES HAVE NOT DELIVERED ALTERNATIVE FDA-APPROVED DRUGS. IN RESPONSE TO THIS UNMET NEED, OUR PROGRAM IS DESIGNED TO TEST MULTIPLE DRUGS TO ADVANCE THEM THROUGH REGULATORY APPROVAL. IN THE FUTURE, WE ENVISION EXPANDING OUR EFFORTS TO OTHER THERAPEUTIC SOLUTIONS (E.G. DEVICES, ALTERNATIVE THERAPIES), THROUGH OUR EVIDENCE-DRIVEN CLINICAL TRIAL NETWORK INFRASTRUCTURE.BEST BIOMARKER PTSD STUDY:DESPITE THE EFFICACY OF PSYCHOTHERAPY AS FIRST-LINE TREATMENT FOR PTSD, LARGE INTER-INDIVIDUAL DIFFERENCES IN OUTCOMES EXIST, WITH ROUGHLY 50% OF PATIENTS RESPONDING TO TREATMENT AND FEWER THAN THAT FULLY REMITTING. THIS GRANT SUPPORTED THE DEVELOPMENT OF A RESPONSE DIAGNOSTIC TEST BASED ON PRELIMINARY FINDINGS FOR A COMBINATION COGNITIVE/IMAGING MARKER RESULTING FROM CVB'S INVESTMENT IN THE COHEN VETERANS CENTER STUDY AT NYU/STANFORD. THE PROGRAM INCLUDED A CLINICAL STUDY AT TWO CENTERS OF OVER 200 SUBJECTS TO REPLICATE THE INITIAL FINDING, AND IS SEEKING QUALIFICATION VIA THE FOOD AND DRUG ADMINISTRATION ("FDA") GUIDANCE TO SUPPORT THE COMMERCIALIZATION AND/OR AVAILABILITY OF THE TEST FOR CLINICAL PRACTICE AND RESEARCH AND DEVELOPMENT. THIS STUDY COMPLETED RECRUITMENT IN DECEMBER 2019 AND SEMINAL RESULTS WHICH DEMONSTRATE THAT AN EEG BASED BIOMARKER CAN PREDICT TREATMENT RESPONSE FOR INDIVIDUALS WITH PTSD OR MDD WERE PUBLISHED IN 2020.PTSD GENETICS PROGRAM:THE PSYCHIATRIC GENETICS CONSORTIUM-PTSD WORKING GROUP - BROAD INSTITUTE COLLABORATION IS SUPPORTING THE LARGEST GLOBAL GENOME WIDE ASSOCIATION STUDY ("GWAS") OF PTSD TO DATE WITH DATA FROM OVER 200,000 INDIVIDUALS ANALYZED. THE MAIN GOAL IS TO UNCOVER THE GENETIC UNDERPINNINGS OF PTSD RISK AND PUBLISH ALL RESULTS. SEMINAL FINDINGS OF THE FIRST PTSD GENETIC RISK LOCI FROM
IRS990/ProgSrvcAccomActy3Grp/Desc0THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PARKINSON'S PROGRESSION MARKERS INITIATIVE (PPMI) DATA SCIENCE MODELING GROUPEXISTING DIAGNOSES FOR COMPLEX BRAIN DISORDERS SUCH AS PARKINSON'S DISEASE (PD) FOCUS ON UNDERSTANDING CLUSTERS OF MAJOR SYMPTOMS. IN ORDER TO DRIVE PROGRESS IN THE DEVELOPMENT OF NEW TREATMENTS IT IS IMPORTANT TO UNDERSTAND THE ROLE OF SPECIFIC BIOLOGICAL PROCESSES IN DETERMINING PATIENT OUTCOMES. IN THIS PROGRAM WE MODEL THE MICHAEL J. FOX FOUNDATION (MJFF) SPONSORED PARKINSON'S PROGRESSION MODEL INITIATIVE (PPMI) STUDY. THE STUDY HAS EVALUATED PARTICIPANTS' CLINICAL STATUS WHILE COLLECTING IMAGING, BEHAVIORAL, 'OMICS AND OTHER ASSESSMENTS LONGITUDINALLY SINCE 2010. IN OUR ALIGNED MISSIONS TO ADVANCE BRAIN HEALTH, MJFF SELECTED CVB'S DATA SCIENCE TEAM TO LEVERAGE THIS COHORT TOGETHER WITH A MULTI-DISCIPLINARY APPROACH TO QUANTITATIVELY EXPLORE, EVALUATE, AND PREDICT DISEASE TRAJECTORY, RISK FACTORS, AND SUBTYPES. GIVEN THE BREADTH AND DEPTH OF THE PPMI DATA AND RICH OPPORTUNITIES TO DEVELOP IMPACTFUL DISEASE MODELS, THE TEAM USE THEIR SUBJECT MATTER EXPERTISE ACROSS TRANSLATIONAL SCIENCE TO GENERATE INSIGHTS FROM 'OMICS, IMAGING, GENETIC AND CLINICAL DATA BY INTEGRATING TECHNIQUES ACROSS ADVANCED STATISTICS, MACHINE LEARNING, AND COMPUTATIONAL MODELING TO FACILITATE PD BIOMARKER DISCOVERY AND DEEPEN OUR UNDERSTANDING OF DISEASE PROGRESSION. IN 2020, WE COMPLETED THE FIRST ANALYSES OF THESE DATA THAT WILL BE PUBLISHED SOON.PTSD & TBI KNOWLEDGEMAP (TRADEMARKED):THE BRAINTRAUMA KNOWLEDGEMAP PROJECT IS USING INFORMATION TECHNOLOGY AND VISUALIZATION TO BUILD AN INNOVATIVE NEW INTERACTIVE TOOL TO EXTRACT INFORMATION FROM PUBLISHED PAPERS FOR THE RESEARCH COMMUNITY. THE WORK INCLUDES EXTRACTION OF PTSD BIOMARKER AND TBI LITERATURE. THIS PROJECT IS PART OF OUR 'KNOWLEDGE ENGINEERING' PROGRAMMING EFFORTS TO MOVE FROM 'BIG DATA' TO 'SMART DATA'.GLOBAL PRECLINICAL DATA FORUM (TRADEMARKED):THE GLOBAL PRECLINICAL DATA FORUM (GPDF) IS A JOINTLY SPONSORED U.S. AND EUROPEAN INITIATIVE THAT ENCOURAGES GLOBAL COLLABORATION TO ADDRESS THE CHALLENGE OF ENSURING THAT PRECLINICAL RESEARCH IS REPRODUCIBLE, ROBUST AND TRANSLATABLE TO SUPPORT DISEASE RESEARCH UTILITY FOR CLINICAL RESEARCH & DEVELOPMENT (R&D). IT SUPPORTS BEST RESEARCH PRACTICES, THE DEVELOPMENT AND IMPLEMENTATION OF DATA QUALITY STANDARDS, PRECLINICAL DATA & TECHNOLOGICAL PLATFORMS, AND TRAINING PROGRAMS FOR THE NEUROSCIENCE COMMUNITY WITH THE GOAL OF ENHANCING THE DATA UTILITY DERIVED FROM PRECLINICAL MODELS. THIS IS OUR THIRD YEAR SUPPORTING WITH THE EUROPEAN COLLEGE OF NEUROPHARMACOLOGY (ECNP) THE WORLD'S FIRST NEGATIVE DATA PRIZE AS AN INCENTIVE FOR PRECLINICAL RESEARCHERS TO PUBLISH "NEGATIVE DATA" RESULTS TO ENSURE ALL NEUROSCIENCE STUDIES PROPERLY ADVANCE KNOWLEDGE. THE PRIZE IS AWARDED TO THE RESEARCHER OR RESEARCH GROUP WHOSE NEUROSCIENCE STUDY BEST EXEMPLIFIES DATA WHERE THE OUTCOMES DO NOT CONFIRM THE EXPECTED RESULTS OR WORKING HYPOTHESIS. THE AWARD WAS PRESENTED DURING THE 2020 VIRTUAL ECNP CONFERENCE.EQIPD QUALITY SYSTEM:THE GPDF AND COHEN VETERANS BIOSCIENCE ARE BOTH MAJOR CONTRIBUTORS TO THE EUROPEAN UNION INNOVATIVE MEDICINE INITIATIVE-FUNDED CONSORTIUM CALLED EQIPD (EQIPD.ORG). THE EQIPD CONSORTIUM HAS DEVELOPED A NOVEL PRECLINICAL RESEARCH QUALITY SYSTEM THAT CAN BE APPLIED IN BOTH PUBLIC AND PRIVATE SECTORS AND IS FREE FOR ANYONE TO USE. THE EQIPD QUALITY SYSTEM WAS DESIGNED TO BE SUITED TO BOOST INNOVATION BY ENSURING THE GENERATION OF ROBUST AND RELIABLE PRECLINICAL DATA WHILE BEING LEAN, EFFECTIVE AND NOT BECOMING A BURDEN THAT COULD NEGATIVELY IMPACT THE FREEDOM TO EXPLORE SCIENTIFIC QUESTIONS. EQIPD DEFINES RESEARCH QUALITY AS THE EXTENT TO WHICH RESEARCH DATA ARE FIT FOR THEIR INTENDED USE. FITNESS, IN THIS CONTEXT, IS DEFINED BY THE STAKEHOLDERS, WHO ARE THE SCIENTISTS DIRECTLY INVOLVED IN THE RESEARCH, BUT
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt020795052
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt02786841
IRS990/PYInvestmentIncomeAmt098872
IRS990/PYOtherExpensesAmt012390028
IRS990/PYOtherRevenueAmt0145524
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0868511
IRS990/PYSalariesCompEmpBnftPaidAmt04994068
IRS990/PYTotalExpensesAmt020170937
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt021039448
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-1692255
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt016036550
IRS990/SavingsAndTempCashInvstGrp/EOYAmt015130098
IRS990ScheduleA/FactsAndCircumstancesTestTxt0COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY DEDICATED TO FAST-TRACKING THE DEVELOPMENT OF DIAGNOSTIC TESTS AND PERSONALIZED THERAPEUTICS FOR THE MILLIONS OF VETERANS AND CIVILIANS IN THE US WHO SUFFER THE DEVASTATING EFFECTS OF TRAUMA-RELATED AND OTHER BRAIN DISORDERS. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MEETS THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB HAS HAD A DONATION BUTTON ON WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. THE ORGANIZATION HAS RUN SEVERAL ONLINE DONATION CAMPAIGNS INCLUDING A "CROWDSOURCED" APPROACH IN 2017 THAT RAISED MORE THAN $100,000 FROM NUMEROUS INDIVIDUAL DONORS. THE ORGANIZATION HAS ACTIVELY PURSUED AND RECEIVED GRANTS FROM GOVERNMENT AND PUBLIC CHARITIES AND FOUNDATIONS FOCUSED ON BRAIN DISEASES. IN CVB'S EARLY YEARS OF EXISTENCE THE SCOPE OF ITS SOLICITATION WAS MORE LIMITED TO PERSONS DEEMED MOST LIKELY TO PROVIDE EARLY FUNDING IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND THE SOLICITATION PROGRAM. DIRECT OUTREACH TO POTENTIAL SUPPORTERS IS INCREASINGLY CONDUCTED BY CVB'S CEO AND OTHER EXECUTIVE TEAM AND SCIENTIFIC STAFF. CVB NOW REGULARLY CONDUCTS BROAD OUTREACH CAMPAIGNS, HAS STAFF DEDICATED TO FUNDRAISING AND SUPPORTER ENGAGEMENT TO SOLICIT CHARITABLE CONTRIBUTIONS FROM THE GENERAL PUBLIC, AND CARRIES ON ACTIVITIES DESIGNED TO ATTRACT SUPPORT FROM GOVERNMENT SOURCES AND PUBLIC CHARITIES. IN THE MOST RECENT FISCAL YEAR CVB HIRED AN EXPERIENCED EXECUTIVE DIRECTOR OF DEVELOPMENT TO FURTHER EXPAND FUNDRAISING INFRASTRUCTURE AND OUTREACH. CVB REGULARLY APPLIES FOR RELEVANT FUNDING FROM GOVERNMENT AGENCIES AND NONPROFIT ORGANIZATIONS. CVB HAS DEVELOPED MATERIALS TO SUPPORT POTENTIAL DONOR ENGAGEMENT, AND WORKS DILIGENTLY TO EXPAND THE NETWORK OF POTENTIAL SUPPORTERS BY ENGAGING WITH BOARD MEMBERS AND STAFF TO CONNECT WITH THEM. CVB'S PUBLIC SUPPORT PERCENTAGE, AS REPORTED FOR 2019, IS 10.51%, AND IS EXPECTED TO INCREASE AS A RESULT OF EXPANDED FUNDRAISING INFRASTRUCTURE AND OUTREACH. THE 2019 RESULT WHEN COMPARED TO THE 2018 PERCENTAGE OF 8.94% IS EVIDENCE OF THE INCREASING BREADTH OF PUBLIC SUPPORT AS CVB FURTHER BUILDS UPON ITS FUNDRAISING EFFORTS. CVB HAS RECEIVED SUPPORT FROM A DIVERSITY OF DONORS AND SOURCES DURING ITS I
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, DAVID BIONDI, MD HAS OVER 20 YEARS OF CLINICAL EXPERIENCE IN MEDICAL PRACTICE AND HELD MEDICAL DIRECTORSHIPS AT THE US NAVAL HOSPITAL IN OKINAWA JAPAN, THE PAIN MANAGEMENT PROGRAM & HEADACHE INSTITUTE AT MARYVIEW MEDICAL CENTER IN PORTSMOUTH VA, THE PAIN DIVISION OF THE MICHIGAN HEAD PAIN & NEUROLOGICAL INSTITUTE IN ANN ARBOR MI, AND THE INTERDISCIPLINARY HEADACHE & PAIN REHABILITATION PROGRAM AT SPAULDING REHABILITATION HOSPITAL IN BOSTON MA. HE WAS PREVIOUSLY AN ASSISTANT NEUROLOGIST AT THE MASSACHUSETTS GENERAL HOSPITAL AND AN INSTRUCTOR IN NEUROLOGY AT HARVARD MEDICAL SCHOOL. DR. BIONDI SERVED AS A TRUSTEE FOR THE UNIVERSITY OF NEW ENGLAND AND WAS CHAIR OF ITS ACADEMIC AND RESEARCH AFFAIRS COMMITTEE AND VICE-CHAIR OF ITS LONG-RANGE PLANNING COMMITTEE. HE ALSO SERVED AS A DIRECTOR AND MEDICAL ADVISOR FOR THE AFTER ACTION NETWORK, A NONPROFIT VETERAN SERVICE ORGANIZATION IN KANSAS CITY MO. HE IS A FELLOW OF THE AMERICAN ACADEMY OF NEUROLOGY. DR. BIONDI HAS OVER 15 YEARS OF EXPERIENCE IN CLINICAL RESEARCH AND DEVELOPMENT OF PHARMACEUTICALS AND MEDICAL DEVICES IN THE NEUROLOGY, PSYCHIATRY, AND PAIN THERAPEUTIC AREAS. HIS EXPERIENCES INCLUDE THE DESIGN, IMPLEMENTATION, MONITORING, AND INTERPRETATION OF PHASE 2 TO PHASE 4 CLINICAL TRIALS AND IN-HOUSE AND FIELD-BASED ACTIVITIES ASSOCIATED WITH INSIGHTS GENERATION, NEW BUSINESS OPPORTUNITIES, EMERGING HEALTH POLICY, KNOWLEDGE TRANSLATION AND IMPLEMENTATION, AND ORGANIZATIONAL EFFECTIVENESS. HE PREVIOUSLY SERVED AS EXECUTIVE DIRECTOR FOR CLINICAL PROGRAMS WITH COHEN VETERANS BIOSCIENCE. DR. BIONDI RECEIVED HIS MEDICAL DEGREE FROM THE UNIVERSITY OF NEW ENGLAND, COLLE
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt016316026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt020795052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt016828176
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt04366629
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt031399759
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt089705642
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0154639
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt098872
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt017365
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0270876
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.10510
IRS990ScheduleA/PublicSupportTotal170Amt09455404
IRS990ScheduleA/SubstantialContributorsTotAmt080250238
IRS990ScheduleA/TenPctFactsCrcmstncsTestCYInd0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt016316026
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt020795052
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt016828176
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt04366629
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt031399759
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt089705642
IRS990ScheduleA/TotalSupportAmt089976518
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearAmt0250000
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearMinus1Amt0250000
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearMinus2Amt0223346
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/TotalAmt0723346
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/CurrentYearAmt01000000
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/CurrentYearMinus1Amt01000000

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$18,865,456
Liabilities
$8,431,760
Net assets
$10,433,696
Revenue
$16,470,665
Expenses
$18,162,920
Net income
-$1,692,255
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.84$0.10$1.74$3.37$1.38$1.99
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.08$3.11$0.03$8.38$14.1$5.70
2023Facts available. Structured filing facts are available, but richer extracted sections are limited.$11.7$3.85$7.89$11.3$15.3$4.00
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$15.6$3.70$11.9$18.1$17.5$0.56
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$18.0$6.83$11.1$16.3$18.1$1.86
2020Detailed filing. Detailed filing data is available for this year.$18.9$8.43$10.4$16.5$18.2$1.69
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$24.2$13.0$11.2$21.0$20.2$0.87
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.4$6.02$10.3$16.8$14.8$2.05
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$14.9$6.58$8.28$4.37$11.3$6.97
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$25.4$10.2$15.3$31.4$16.3$15.1
2015Detailed filing. Detailed filing data is available for this year.$0.45$0.33$0.12$0.07$0.65$0.58